BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 19008479)

  • 21. KCNE1 alters the voltage sensor movements necessary to open the KCNQ1 channel gate.
    Osteen JD; Gonzalez C; Sampson KJ; Iyer V; Rebolledo S; Larsson HP; Kass RS
    Proc Natl Acad Sci U S A; 2010 Dec; 107(52):22710-5. PubMed ID: 21149716
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A new KCNQ1 mutation at the S5 segment that impairs its association with KCNE1 is responsible for short QT syndrome.
    Moreno C; Oliveras A; de la Cruz A; Bartolucci C; Muñoz C; Salar E; Gimeno JR; Severi S; Comes N; Felipe A; González T; Lambiase P; Valenzuela C
    Cardiovasc Res; 2015 Sep; 107(4):613-23. PubMed ID: 26168993
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Physiological Functions, Biophysical Properties, and Regulation of KCNQ1 (K
    Sanguinetti MC; Seebohm G
    Adv Exp Med Biol; 2021; 1349():335-353. PubMed ID: 35138621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biophysical properties of mutant KCNQ1 S277L channels linked to hereditary long QT syndrome with phenotypic variability.
    Aidery P; Kisselbach J; Schweizer PA; Becker R; Katus HA; Thomas D
    Biochim Biophys Acta; 2011 Apr; 1812(4):488-94. PubMed ID: 21241800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Insulin suppresses IKs (KCNQ1/KCNE1) currents, which require β-subunit KCNE1.
    Wu M; Obara Y; Norota I; Nagasawa Y; Ishii K
    Pflugers Arch; 2014 May; 466(5):937-46. PubMed ID: 24068254
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gating-related molecular motions in the extracellular domain of the IKs channel: implications for IKs channelopathy.
    Wang YH; Jiang M; Xu XL; Hsu KL; Zhang M; Tseng GN
    J Membr Biol; 2011 Feb; 239(3):137-56. PubMed ID: 21152909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacological rescue of specific long QT variants of KCNQ1/KCNE1 channels.
    Zou X; Wu X; Sampson KJ; Colecraft HM; Larsson HP; Kass RS
    Front Physiol; 2022; 13():902224. PubMed ID: 36505078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long QT syndrome-associated mutations in the S4-S5 linker of KvLQT1 potassium channels modify gating and interaction with minK subunits.
    Franqueza L; Lin M; Shen J; Splawski I; Keating MT; Sanguinetti MC
    J Biol Chem; 1999 Jul; 274(30):21063-70. PubMed ID: 10409658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanisms of disease pathogenesis in long QT syndrome type 5.
    Harmer SC; Wilson AJ; Aldridge R; Tinker A
    Am J Physiol Cell Physiol; 2010 Feb; 298(2):C263-73. PubMed ID: 19907016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms by which atrial fibrillation-associated mutations in the S1 domain of KCNQ1 slow deactivation of IKs channels.
    Restier L; Cheng L; Sanguinetti MC
    J Physiol; 2008 Sep; 586(17):4179-91. PubMed ID: 18599533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A molecular mechanism for adrenergic-induced long QT syndrome.
    Wu J; Naiki N; Ding WG; Ohno S; Kato K; Zang WJ; Delisle BP; Matsuura H; Horie M
    J Am Coll Cardiol; 2014 Mar; 63(8):819-27. PubMed ID: 24184248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. KCNE2 confers background current characteristics to the cardiac KCNQ1 potassium channel.
    Tinel N; Diochot S; Borsotto M; Lazdunski M; Barhanin J
    EMBO J; 2000 Dec; 19(23):6326-30. PubMed ID: 11101505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. KCNE1 and KCNE3 modulate KCNQ1 channels by affecting different gating transitions.
    Barro-Soria R; Ramentol R; Liin SI; Perez ME; Kass RS; Larsson HP
    Proc Natl Acad Sci U S A; 2017 Aug; 114(35):E7367-E7376. PubMed ID: 28808020
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a novel Long QT syndrome mutation G52R-KCNE1 in a Chinese family.
    Ma L; Lin C; Teng S; Chai Y; Bähring R; Vardanyan V; Li L; Pongs O; Hui R
    Cardiovasc Res; 2003 Sep; 59(3):612-9. PubMed ID: 14499862
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The
    Wang Y; Eldstrom J; Fedida D
    Mol Pharmacol; 2020 Feb; 97(2):132-144. PubMed ID: 31722973
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Slow delayed rectifier potassium current blockade contributes importantly to drug-induced long QT syndrome.
    Veerman CC; Verkerk AO; Blom MT; Klemens CA; Langendijk PN; van Ginneken AC; Wilders R; Tan HL
    Circ Arrhythm Electrophysiol; 2013 Oct; 6(5):1002-9. PubMed ID: 23995305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dominant-negative KvLQT1 mutations underlie the LQT1 form of long QT syndrome.
    Shalaby FY; Levesque PC; Yang WP; Little WA; Conder ML; Jenkins-West T; Blanar MA
    Circulation; 1997 Sep; 96(6):1733-6. PubMed ID: 9323054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The A-kinase anchoring protein Yotiao facilitates complex formation between adenylyl cyclase type 9 and the IKs potassium channel in heart.
    Li Y; Chen L; Kass RS; Dessauer CW
    J Biol Chem; 2012 Aug; 287(35):29815-24. PubMed ID: 22778270
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biophysical characteristics of a new mutation on the KCNQ1 potassium channel (L251P) causing long QT syndrome.
    Deschênes D; Acharfi S; Pouliot V; Hegele R; Krahn A; Daleau P; Chahine M
    Can J Physiol Pharmacol; 2003 Feb; 81(2):129-34. PubMed ID: 12710526
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long QT syndrome-associated calmodulin variants disrupt the activity of the slowly activating delayed rectifier potassium channel.
    McCormick L; Wadmore K; Milburn A; Gupta N; Morris R; Held M; Prakash O; Carr J; Barrett-Jolley R; Dart C; Helassa N
    J Physiol; 2023 Sep; 601(17):3739-3764. PubMed ID: 37428651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.